Syneos Health, Inc. - stock earnings
Stock symbol SYNH is outdated, potentially delisted? Maybe it is available on other exchange?
SYNH Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | 55.5 million USD | 1.4 billion USD |
| 2022Q3 | 87.0 million USD | 1.3 billion USD |
| 2022Q2 | 77.7 million USD | 1.4 billion USD |
| 2022Q1 | 46.2 million USD | 1.3 billion USD |
| 2021Q4 | 76.0 million USD | 1.4 billion USD |
| 2021Q3 | 78.2 million USD | 1.3 billion USD |
| 2021Q2 | 41.9 million USD | 1.3 billion USD |
| 2021Q1 | 38.7 million USD | 1.2 billion USD |
| 2020Q4 | 91.9 million USD | 1.1 billion USD |
| 2020Q3 | 63.4 million USD | 1.1 billion USD |
| 2020Q2 | 3.9 million USD | 1.0 billion USD |
SYNH Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 266.5 million USD | 5.4 billion USD |
| 2021 | 234.8 million USD | 5.2 billion USD |
| 2020 | 192.8 million USD | 4.4 billion USD |
| 2019 | 131.3 million USD | 4.7 billion USD |
| 2018 | 24.3 million USD | 4.4 billion USD |
| 2017 | -138.5 million USD | 1.9 billion USD |
SYNH
Price: $42.98
52 week price:
Earnings Per Share: 3.92 USD
P/E Ratio: 61.40
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 1.0 million
Ebitda: -29.0 millionMarket Capitalization: 4.3 billion